SPONSOR
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Total Trials
5
Recruiting
5
Phases
Phase 3, Phase 1, Phase 2
Conditions studied: Metastatic Breast CancerNon-Small Cell Lung CancerSolid MalignanciesLung Cancer (Non-Small Cell)Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Metastatic Breast Cancer, Non-Small Cell Lung Cancer, Solid Malignancies, Lung Cancer (Non-Small Cell).
The trial portfolio spans Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
How many clinical trials has Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., of which 5 are actively recruiting participants. These trials cover conditions including Metastatic Breast Cancer, Non-Small Cell Lung Cancer, Solid Malignancies. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. research focus on?
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. clinical trials span Metastatic Breast Cancer, Non-Small Cell Lung Cancer, Solid Malignancies, Lung Cancer (Non-Small Cell), Small Cell Lung Cancer. The research pipeline includes Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. clinical trial?
To participate in a Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. trials with current recruitment status updated daily.
Clinical Trials by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
NCT06081959 Phase 3
Recruiting
Study of SKB264 for Locally Advanced, Recurrent or Metastatic HR+/HER2- Breast Cancer
Metastatic Breast Cancer
NCT06670196 Phase 3
Recruiting
A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
NCT06725381 Phase 1
Recruiting
A Phase 1 Study of SKB571 in Subjects With Advanced Solid Tumors
Solid Malignancies
NCT07230405 Phase 2
Recruiting
A Phase II Study of SKB571 in Patients With Lung Cancer
Lung Cancer (Non-Small Cell)
NCT07296809 Phase 2
Recruiting
SKB500 Combinations in Patients With Small Cell Lung Cancer
Small Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology